Two Sigma Securities, LLC Eli Lilly & CO Call Options Transaction History

Two Sigma Securities, LLC

$5.78 Billion
Q3 2024

Call Options

26 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$772.14 - $960.02 $1.47 Million - $1.82 Million	-1,900 Reduced 10.5%	16,200 $14.4 Million
Q2 2024 Aug 14, 2024	SELL	$724.87 - $909.04 $11.6 Million - $14.5 Million	-16,000 Reduced 46.92%	18,100 $16.4 Million
Q1 2024 May 15, 2024	SELL	$592.2 - $792.28 $19.2 Million - $25.7 Million	-32,500 Reduced 48.8%	34,100 $26.5 Million
Q4 2023 Feb 14, 2024	BUY	$525.19 - $619.13 $12.8 Million - $15.1 Million	24,400 Added 57.82%	66,600 $38.8 Million
Q3 2023 Nov 14, 2023	SELL	$434.7 - $599.3 $5.22 Million - $7.19 Million	-12,000 Reduced 22.14%	42,200 $22.7 Million
Q2 2023 Aug 14, 2023	BUY	$350.74 - $468.98 $7.68 Million - $10.3 Million	21,900 Added 67.8%	54,200 $25.4 Million
Q1 2023 May 15, 2023	BUY	$310.63 - $364.82 $5.9 Million - $6.93 Million	19,000 Added 142.86%	32,300 $11.1 Million
Q4 2022 Feb 14, 2023	BUY	$321.55 - $374.67 $2.96 Million - $3.45 Million	9,200 Added 224.39%	13,300 $4.87 Million
Q3 2022 Nov 14, 2022	BUY	$296.48 - $337.87 $29,648 - $33,787	100 Added 2.5%	4,100 $1.33 Million
Q2 2022 Aug 15, 2022	BUY	$278.73 - $327.27 $836,190 - $981,810	3,000 Added 300.0%	4,000 $1.3 Million
Q1 2022 May 16, 2022	SELL	$234.69 - $291.66 $1.38 Million - $1.72 Million	-5,900 Reduced 85.51%	1,000 $286,000
Q3 2021 Nov 15, 2021	SELL	$221.6 - $272.71 $797,760 - $981,755	-3,600 Reduced 34.29%	6,900 $1.59 Million
Q2 2021 Aug 16, 2021	SELL	$180.55 - $233.54 $1.14 Million - $1.47 Million	-6,300 Reduced 37.5%	10,500 $2.41 Million
Q4 2020 Feb 16, 2021	BUY	$130.46 - $172.63 $1.59 Million - $2.11 Million	12,200 Added 265.22%	16,800 $2.84 Million
Q3 2020 Nov 16, 2020	SELL	$146.22 - $169.13 $1.8 Million - $2.08 Million	-12,300 Reduced 72.78%	4,600 $681,000
Q2 2020 Sep 10, 2020	SELL	$136.42 - $164.18 $5.01 Million - $6.03 Million	-36,700 Reduced 68.47%	16,900 $2.78 Million
Q1 2020 May 15, 2020	SELL	$119.05 - $147.35 $10.4 Million - $12.8 Million	-87,100 Reduced 61.9%	53,600 $7.44 Million
Q4 2019 Feb 14, 2020	BUY	$106.92 - $132.43 $15 Million - $18.6 Million	140,700 New	140,700 $18.5 Million
Q3 2019 Nov 14, 2019	SELL	$106.79 - $116.16 $8.52 Million - $9.27 Million	-79,800 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$110.79 - $129.32 $3.2 Million - $3.74 Million	28,900 Added 56.78%	79,800 $8.84 Million
Q1 2019 May 15, 2019	SELL	$111.31 - $131.02 $623,336 - $733,712	-5,600 Reduced 9.91%	50,900 $6.61 Million
Q4 2018 Feb 14, 2019	SELL	$105.9 - $118.64 $4.12 Million - $4.62 Million	-38,900 Reduced 40.78%	56,500 $6.54 Million
Q3 2018 Nov 14, 2018	SELL	$85.86 - $107.31 $8.89 Million - $11.1 Million	-103,500 Reduced 52.04%	95,400 $10.2 Million
Q2 2018 Aug 14, 2018	BUY	$75.7 - $86.88 $741,860 - $851,424	9,800 Added 5.18%	198,900 $17 Million
Q1 2018 May 15, 2018	BUY	$74.21 - $87.6 $12.1 Million - $14.3 Million	163,500 Added 638.67%	189,100 $14.6 Million
Q4 2017 Feb 14, 2018	BUY	$81.94 - $87.89 $2.1 Million - $2.25 Million	25,600	25,600 $2.16 Million

Others Institutions Holding LLY

# of Institutions

4,003

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

Lilly Endowment Inc Indianapolis, IN

96.9M
Shares

$73 Billion
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

73.8M
Shares

$55.6 Billion
1.2% of portfolio
Black Rock Inc. New York, NY

65.9M
Shares

$49.6 Billion
1.37% of portfolio
Pnc Financial Services Group, Inc. Pittsburgh, PA

51.4M
Shares

$38.7 Billion
29.2% of portfolio
State Street Corp Boston, MA

33.9M
Shares

$25.5 Billion
1.24% of portfolio

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $716B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Securities, LLC with notifications on news.

Account